Title of article :
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol
Author/Authors :
Andre Di Lenarda، نويسنده , , Gastone Sabbadini، نويسنده , , Luc Salvatore De Santo، نويسنده , , Gianfranco Sinagra، نويسنده , , Luis Mestroni، نويسنده , , Bruno Pinamonti MD، نويسنده , , Dario Gregori، نويسنده , , Fulvio Ciani، نويسنده , , Aureo Muzzi، نويسنده , , Silvio Klugmann، نويسنده , , Fulvio Camerini and The Heart-Muscle Disease Study Group، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1999
Abstract :
OBJECTIVES
The purpose of this study was to analyze whether long-term treatment with the nonselective beta-adrenergic blocking agent carvedilol may have beneficial effects in patients with dilated cardiomyopathy (DCM), who are poor responders in terms of left ventricular (LV) function and exercise tolerance to chronic treatment with the selective beta-blocker metoprolol.
BACKGROUND
Although metoprolol has been proven to be beneficial in the majority of patients with heart failure, subset of the remaining patients shows long-term survival without satisfactory clinical improvement.
METHODS
Thirty consecutive DCM patients with persistent LV dysfunction (ejection fraction ≤40%) and reduced exercise tolerance (peak oxygen consumption <25 ml/kg/min) despite chronic (>1 year) tailored treatment with metoprolol and angiotensin-converting enzyme inhibitors were enrolled in 12-month, open-label, parallel trial and were randomized either to continue on metoprolol (n = 16, mean dosage 142 ± 44 mg/day) or to cross over to maximum tolerated dosage of carvedilol (n = 14, mean dosage 74 ± 23 mg/day).
RESULTS
At 12 months, patients on carvedilol, compared with those continuing on metoprolol, showed decrease in LV dimensions (end-diastolic volume −8 ± 7 vs. +7 ± 6 ml/m2, p = 0.053; end-systolic volume −7 ± 5 vs. +6 ± 4 ml/m2, p = 0.047), an improvement in LV ejection fraction (+7 ± 3% vs. −1 ± 2%, p = 0.045), reduction in ventricular ectopic beats (−12 ± 9 vs. +62 ± 50 n/h, p = 0.05) and couplets (−0.5 ± 0.4 vs. +1.5 ± 0.6 n/h, p = 0.048), no significant benefit on symptoms and quality of life and negative effect on peak oxygen consumption (−0.6 ± 0.6 vs. +1.3 ± 0.5 ml/kg/min, p = 0.03).
CONCLUSIONS
In DCM patients who were poor responders to chronic metoprolol, carvedilol treatment was associated with favorable effects on LV systolic function and remodeling as well as on ventricular arrhythmias, whereas it had negative effect on peak oxygen consumption.
Keywords :
ACE , ejection fraction , Left ventricular , angiotensin-converting enzyme , Confidence interval , Dilated cardiomyopathy , CI , LV , NYHA , New York Heart Association , EF , EDV , DCM , Vo2 , end-diastolic volume , end-systolic volume , ESV , volume of oxygen consumption
Journal title :
JACC (Journal of the American College of Cardiology)
Journal title :
JACC (Journal of the American College of Cardiology)